Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment

BACKGROUND: Dickkopf-1 (DKK1) regulates bone formation by inhibiting canonical Wnt/β-catenin pathway signaling, and indirectly enhances osteoclastic activity by altering the expression ratio of receptor activator of nuclear factor-κB ligand (RANKL) relative to osteoprotegerin (OPG). However, it is d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Eunhee, Ha, Jeonghoon, Baek, Ki-Hyun, Kang, Moo Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743595/
https://www.ncbi.nlm.nih.gov/pubmed/34875817
http://dx.doi.org/10.3803/EnM.2021.1248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743595/
https://www.ncbi.nlm.nih.gov/pubmed/34875817
http://dx.doi.org/10.3803/EnM.2021.1248

Ejemplares similares